Christine Dopp
Physician Assistant · Bloomsburg, PANPI 1548268113
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 587 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 26.3% of the total. 2025 is the largest year on record at $2,498, 2.8 times the $877 reported in 2021. Among physician assistant clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 587 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$3K
- Johnson & Johnson$1K
- Neurocrine Biosciences, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$994
- AbbVie$898
- plus $2K from 10 others
What the payments were for
- Food & beverage$9,56997%
- Education$2893%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 154 | $2,597 |
| Johnson & Johnson | 71 | $1,313 |
| Neurocrine Biosciences, Inc. | 56 | $1,048 |
| Otsuka America Pharmaceutical, Inc. | 54 | $1,021 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 58 | $994 |
| AbbVie | 69 | $898 |
| Lundbeck LLC | 38 | $531 |
| Axsome Therapeutics, Inc. | 21 | $359 |
| Alkermes, Inc. | 13 | $306 |
| Vanda Pharmaceuticals Inc. | 14 | $283 |
| Corium, LLC | 21 | $206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $191 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Sage Therapeutics, LLC | 1 | $19 |
| Novo Nordisk | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$122
- Austedo XR$119
- INGREZZA$115
How this compares
$9,858 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 50 | $464,763 |
| Austedo XrDeutetrabenazine | 11 | $140,682 |
| VraylarCariprazine Hcl | 65 | $108,317 |
| Invega SustennaPaliperidone Palmitate | 24 | $82,588 |
| AristadaAripiprazole Lauroxil | 15 | $46,180 |
| CaplytaLumateperone Tosylate | 12 | $27,853 |
| TrintellixVortioxetine Hydrobromide | 31 | $24,971 |
| Chlorpromazine Hcl | 46 | $15,994 |
| Lurasidone Hcl | 20 | $7,237 |
| Olanzapine OdtOlanzapine | 32 | $5,966 |
| Aripiprazole | 75 | $4,893 |
| Oxcarbazepine | 39 | $4,185 |
| Clozapine | 38 | $4,118 |
| Buspirone Hcl | 159 | $2,230 |
| Olanzapine | 90 | $2,207 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr | $2,597 | $605,44561 claims |
| AbbVieVraylar | $898 | $108,31765 claims |
| Johnson & JohnsonInvega Sustenna | $1,313 | $82,58824 claims |
| Alkermes, Inc.Aristada | $306 | $46,18015 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $994 | $27,85312 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $191 | $24,97131 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Bloomsburg
- Erin CrownState College$1.2M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Jeffrey CameronWashington$89K
- Dorissa BrivchikPittsburgh$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.